Structure of DtpA from E. coli in complex with Valganciclovir provides insights into drug binding of human PepT1

January 15, 2019

Ural-Blimke, Y., Flayhan, A., Strauss, J., et al.

Journal of the American Chemical Society 2019, vol: 141(6) doi: 10.1021/jacs.8b11343


Members of the solute carrier 15 family (SLC15) transport di- and tripeptides as well as peptidomimetic drugs across the cell membrane. Structures of bacterial homologues have provided valuable information on the binding and transport of their natural substrates, but many do not transport medically relevant drugs. In contrast, a homologue from Escherichia coli, DtpA (dipeptide and tripeptide permease), shows a high similarity to human PepT1 (SLC15A1) in terms of ligand selectivity and transports a similar set of drugs. Here, we present the crystal structure of DtpA in ligand-free form (at 3.30 Å resolution) and in complex with the antiviral prodrug valganciclovir (at 2.65 Å resolution) supported by biochemical data. We show that valganciclovir unexpectedly binds with the ganciclovir moiety mimicking the N-terminal residue of a canonical peptide substrate. On the basis of a homology model we argue that this binding mode also applies to the human PepT1 transporter. Our results provide new insights into the binding mode of prodrugs and will assist the rational design of drugs with improved absorption rates.

View Publication

Topics: Prometheus, nanoDSF, Monolith, MST, Membrane Proteins, Publications

Previous Article
The NanoTemper Story – Chapter 3: The Prometheus
The NanoTemper Story – Chapter 3: The Prometheus

By 2014, NanoTemper had won a slew of awards for the Monolith. Labs throughout Europe were using MST to mea...

Up next
Improve biopharmaceutical development through stability measurements spanning the product life-cycle with Prometheus
Improve biopharmaceutical development through stability measurements spanning the product life-cycle with Prometheus

Stability of biopharmaceuticals is a complex matrix of parameters that plays a crucial role through the ent...

Have a question about Prometheus?

Contact Specialist

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!